FAsenra Safety Trial in India

Trial Identifier: D3250C00093
Sponsor: AstraZeneca
Collaborator:
Not applicable
NCTID:: NCT05384938
Start Date: November 2021
Primary Completion Date: July 2023
Study Completion Date: July 2023

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
Hindi Translation
Marathi Translation
Telugu Translation
Bengali Translation
Urdu Translation
Kannada Translation
Tamil Translation

Trial Locations

Country Location
IN Bengaluru, IN, 560099
IN Chennai, IN, 600035
IN Delhi, IN, 110029
IN Hyderabad, IN, 500084
IN Jaipur, IN, 302039
IN Jodhpur, IN, 342005
IN Luknow, IN, 226003
IN Mumbai, IN, 400008
IN New Delhi, IN, 110060
IN Noida, IN, 201 301
IN Noida, IN, 201304
IN Noida, IN, 201301
IN Vishakhapatnam, IN, 530002